Nachtigall L B, Boepple P A, Seminara S B, Khoury R H, Sluss P M, Lecain A E, Crowley W F
Reproductive Endocrine Unit, Massachusetts General Hospital, Boston 02114, USA.
J Clin Endocrinol Metab. 1996 Oct;81(10):3520-5. doi: 10.1210/jcem.81.10.8855795.
To evaluate the physiology of inhibin B in the human male, we measured serum concentrations in normal adult men and men with isolated GnRH deficiency before and during long-term replacement with pulsatile GnRH. At baseline, inhibin B levels in the GnRH-deficient men (n = 31) were significantly lower than normal controls (85 +/- 10 pg/mL vs. 239 +/- 14 pg/mL; P < .01) and correlated positively with pretreatment testicular volume (r = .80, P = .001) and a history of spontaneous puberty, suggesting additional maturational influences on the both testicular volume and inhibin B secretion. Pulsatile GnRH administration was associated with significant increases in inhibin B, with levels averaging 108 +/- 7 pg/mL when serum LH, FSH, and T concentrations had reached the normal adult male range (n = 22; P = .02 vs. baseline). Continued GnRH administration for at least an additional year was not associated with further increases in inhibin B concentrations. Throughout the course of long-term pulsatile GnRH replacement, serum FSH levels were negatively correlated with inhibin B concentrations (e.g. r = -.71, P < 0.01; n = 14 treated 12 months after normalization of T). Although inhibin B concentrations did not correlated with sperm density during therapy, rates of fertility were higher in patients with higher baseline levels (inhibin B > or = 60 pg/mL). Increases in serum concentrations of inhibin B occurring during GnRH replacement demonstrate the gonadotropin regulation of gonadal inhibin B secretion. However, the variation in baseline inhibin B levels before GnRH administration suggests an additional gonadotropin-independent level of modulation. The negative correlation between FSH and inhibin B secretion in GnRH-deficient men receiving long-term GnRH replacement is consistent with a putative role of inhibin B in the negative feedback regulation of FSH, although direct confirmation of this role requires further investigation.
为评估抑制素B在男性体内的生理学特性,我们检测了正常成年男性以及患有孤立性促性腺激素释放激素(GnRH)缺乏症的男性在长期脉冲式GnRH替代治疗前后的血清浓度。在基线时,GnRH缺乏症男性(n = 31)的抑制素B水平显著低于正常对照组(85±10 pg/mL对239±14 pg/mL;P <.01),且与治疗前睾丸体积呈正相关(r =.80,P =.001)以及与自然青春期病史相关,提示对睾丸体积和抑制素B分泌存在额外的成熟影响。脉冲式GnRH给药与抑制素B显著升高相关,当血清促黄体生成素(LH)、促卵泡生成素(FSH)和睾酮(T)浓度达到正常成年男性范围时,其水平平均为108±7 pg/mL(n = 22;与基线相比P =.02)。继续给予GnRH至少额外一年与抑制素B浓度进一步升高无关。在长期脉冲式GnRH替代治疗过程中,血清FSH水平与抑制素B浓度呈负相关(例如r = -.71,P <0.01;n = 14,在T正常化后治疗12个月)。尽管治疗期间抑制素B浓度与精子密度无关,但基线水平较高(抑制素B≥60 pg/mL)的患者生育率更高。GnRH替代治疗期间血清抑制素B浓度的升高证明了促性腺激素对性腺抑制素B分泌的调节作用。然而,GnRH给药前基线抑制素B水平的变化提示存在额外的不依赖促性腺激素的调节水平。接受长期GnRH替代治疗的GnRH缺乏症男性中FSH与抑制素B分泌之间的负相关与抑制素B在FSH负反馈调节中的假定作用一致,尽管直接证实这一作用需要进一步研究。